Experienced in Clear Cell Sarcoma

Dr. William M. Newberry

Oncology | Hematology
Bend Memorial Clinic PC
1501 Ne Medical Ctr Dr, 
Bend, OR 
Accepting New Patients
Offers Telehealth
Experienced in Clear Cell Sarcoma
Bend Memorial Clinic PC
1501 Ne Medical Ctr Dr, 
Bend, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

William Newberry is an Oncologist and a Hematologist in Bend, Oregon. Dr. Newberry is rated as an Experienced provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Newberry is currently accepting new patients.

His clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology
Licenses
Internal Medicine in SC
Hospital Affiliations
St Charles Medical Center Prineville
St Charles Medical Center - Bend
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

BEND MEMORIAL CLINIC PC
1501 Ne Medical Ctr Dr, Bend, OR 97701

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: October 01, 2025
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer
Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 05, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Phase: Phase 3
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Other
Study Phase: Phase 3
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
View 3 Less Clinical Trials
Similar Doctors
Advanced in Clear Cell Sarcoma
Dr. Bryden T. Considine
Hematology Oncology | Hematology | Oncology
Advanced in Clear Cell Sarcoma
Dr. Bryden T. Considine
Hematology Oncology | Hematology | Oncology

St Charles Health System Inc

1541 Nw Canal Blvd, Cancer Cent, 
Redmond, OR 
 (16.3 miles away)
541-706-5800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bryden Considine is a Hematologist Oncology specialist and a Hematologist in Redmond, Oregon. Dr. Considine is rated as an Advanced provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Familial Wilms Tumor 2, and Wilms Tumor. Dr. Considine is currently accepting new patients.

Advanced in Clear Cell Sarcoma
Dr. Richard D. Reed
Hematology Oncology | Hematology | Oncology
Advanced in Clear Cell Sarcoma
Dr. Richard D. Reed
Hematology Oncology | Hematology | Oncology

St Charles Health System Inc

1541 Nw Canal Blvd, Cancer Cent, 
Redmond, OR 
 (16.3 miles away)
541-706-5800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Richard Reed is a Hematologist Oncology specialist and a Hematologist in Redmond, Oregon. Dr. Reed is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Chronic Lymphocytic Leukemia (CLL). Dr. Reed is currently accepting new patients.

Advanced in Clear Cell Sarcoma
Dr. William G. Schmidt
Hematology Oncology | Oncology
Advanced in Clear Cell Sarcoma
Dr. William G. Schmidt
Hematology Oncology | Oncology

Bend Memorial Clinic PC

1501 Ne Medical Ctr Dr, 
Bend, OR 
 (0.1 miles away)
541-382-2811
Languages Spoken:
English, Icelandic
See accepted insurances
Accepting New Patients
Offers Telehealth

William Schmidt is a Hematologist Oncology specialist and an Oncologist in Bend, Oregon. Dr. Schmidt is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Testicular Yolk Sac Tumor, and Virilizing Ovarian Tumor. Dr. Schmidt is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Newberry's expertise for a condition
ConditionClose
    View All 20 Advanced Conditions
    View All 111 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile